Our disruptive software technology identifies drug candidates based on the geometry of protein binding sites and their drug-target interactions, paving new ways to explore the drug-target space at a ground-breaking level of precision.
Predictions based on 3D protein structure & binding affinity data.
Exploits hidden knowledge in vast numbers of protein-ligand complexes found in the Protein Data Bank (PDB).
Delivers high scaffold diversity.